Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9522241
Controlled release nanoparticulate matter delivery system
granted -
US 9523079
Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
granted -
US 9517270
Lipocationic polymers and uses thereof
granted -
US 9512401
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy
granted -
US 9511152
Multicolored pH-activatable fluorescence nanoplatform
granted -
US 9512204
Humanized pertussis antibodies and uses thereof
granted -
US 9504658
Stabilized HME composition with small drug particles
granted -
US 9504701
Methods for treating viral infections using hydrogen sulfide donors
granted -
US 9504742
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted -
US 9499588
Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof
granted -
US 9499595
Development of influenza A antivirals
granted -
US 9502711
Fabrication of biscrolled fiber using carbon nanotube sheet
granted -
US 9492477
Compositions comprising citrate and applications thereof
granted -
US 9486456
Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof
granted -
US 9481692
Heterocyclic modulators of HIF activity for treatment of disease
granted -
US 9481877
Engineered primate L-methioninase for therapeutic purposes
granted -
US 9474730
Methods and compositions for use with K-ras mediated disorders
granted -
US 9469878
Methods of treating cancer comprising targeting NQO1
granted -
US 9463254
Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI
granted -
US 9458095
Oligo-benzamide compounds and their use in treating cancers
granted -
US 9457002
Antimicrobial compositions comprising glyceryl nitrates
granted -
US 9452182
Collateral gene inactivation biomarkers and targets for cancer therapy
granted -
US 9446022
Pro-neurogenic compounds
granted -
US 9447047
Inhibitors of protein phosphatase-1 and uses thereof
granted